Re: Mangham C. Harm reduction and illegal drugs: the real debate (commentary) CJPH 2001; 92(3): 204-5.

1. Paquette D, Snider J, Bouchard F, et al. Performance of screening mammography in organized programs in Canada in 1996. CMAJ 2000;163:1133-38. 2. Ballard-Barbash R, Klabunde C, Paci E, et al. Breast cancer screening in 21 countries: Delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 1999;8:417-26. 3. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: Overview of Swedish randomised trials. Lancet 1993;341:973-78. 4. Fletcher SW, Black W, Harris R. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993;85:1644-56. 5. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: A metaanalysis. JAMA 1995;273:149-54. 6. National Program for the Early Detection of Breast Cancer. National Accreditation Requirements. Canberra, Australia: Commonwealth Department of Human Services and Health, 1994. 7. Anonymous. Organizing Assessment. Sheffield, UK: National Health Service Breast Screening Programme Publications, 1989. 8. Olivotto IA, Bancej C, Goel V, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 2001;165:277-83. 9. Feintimen IS. Pensive women, painful vigils: Consequences of delay in assessment of mammographic abnormalities. Lancet 1988; 1(8593):1041-42. 10. Rimer BK, Blumann LG. The psychological consequences of mammography. J Natl Cancer Inst Monogr 1997;22:131-38. 11. Lerman C, Trock B, Rimer BK, et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61. 12. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Pub Health Med 1998;20:396-403. 13. Thorne SE, Harris SR, Hislop TG, et al. The experience of waiting for a diagnosis after an abnormal mammogram. The Breast J 1999;5:42-51. 14. Miller AB. Organized breast screening programs in Canada. CMAJ 2000;163:1150-51. 15. Olivotto IA, Kan L, King S. Waiting for a diagnosis after an abnormal screening mammogram. Can J Public Health 2000;91(2):113-17. 16. Katz SJ, Hislop TG, Thomas DB, et al. Delay from symptom to diagnosis and treatment of breast cancer in Washington State and British Columbia. Med Care 1993;31:264-68. 17. Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Research Treat 1996;40:53-64. 18. Olivotto IA, Kan L, D’ychokova Y, et al. Ten years of breast screening in the Screening Mammography Program of British Columbia: 1988-1997. J Med Screen 2000;7:152-59. 19. Kan L, Olivotto IA, Coldman AJ, et al. Volume and screening performance. Radiology 2000;215:563-67. 20. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999;353:1119-26. 21. Caines JS, Chantziantouiou K, Wright BA, et al. Nova Scotia Breast Screening Program experience: Use of needle core biopsy in the diagnosis of screening-detected abnormalities. Radiology 1996;198:125-30.